News - MedTech

£77m for ‘transformative’ stem cell MedTech bit.bio

Cambridge MedTech bit.bio has raised £77 million to develop its synthetic biology cell programming ...

Silence Therapeutics wins US backer as it seeks to delist from AIM

A London MedTech which is looking to delist from the London Stock Exchange’s alternative AIM marke...

Diabetes startup Occuity rejuvenates key designer behind iPhone

A key member of the design team behind Apple's flagship products is now tackling diabetes. Daniel...

£13m investment for MedTech Closed Loop Medicine

Closed Loop Medicine has closed £13 million of new investment from a range of top UK and European v...

Insomnia startup SleepCogni to launch in US

SleepTech startup SleepCogni has raised £1.4 million to scale the business to commercialise into th...

Could listed BiVictriX Therapeutics deliver cancer breakthrough?

BiVictriX Therapeutics, led by 33-year-old CEO Tiffany Thorn, is trying to fix one of the longest-st...

Arm founder appointed chair of MedTech bit.bio

A co-founder of chipmaking giant Arm has been appointed chairman of Cambridge MedTech bit.bio. Dr...

Oxford BioDynamics share placing to boost COVID, cancer tests

Oxford BioDynamics has raised £3.6 million in a share placing. The listed biotechnology company ...

This tech-powered T-shirt could save your life

A wearable ECG monitoring vest aimed at people with abnormal heartbeats - arrhythmia - has been crea...

Firm behind COVID ‘sugar test’ appoints new CEO

Iceni Diagnostics has appointed a new CEO as the company prepares to bring its revolutionary product...

£9m to launch at-home blood testing tech tackling cancer

MedTech Entia has raised close to £9 million to launch an at-home blood testing solution for cancer...

Implantable heart tech predicts a patient’s risk of dying

Implantable heart technology is being used in Manchester to assess when a patient is at high risk of...